US2018080006A1PendingUtilityA1
Cell culture medium
Est. expirySep 25, 2029(~3.2 yrs left)· nominal 20-yr term from priority
C12N 5/0018C12N 5/0602C12N 2502/11C12N 2500/84
39
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a cell culture medium for culturing human cells comprising an anti-coagulated total blood material wherein the hemoglobin level is from about 8 to about 16 g/dl. More particularly, the invention provides a cell culture medium in which cells present in the blood are disrupted and the insoluble remnants of the lysated cells are removed. Further, the invention provides a method for the preparation of a cell culture medium for culturing human cells, according to the invention.
Claims
exact text as granted — not AI-modified1 . A cell culture medium for culturing human cells comprising an anti-coagulated total blood material wherein the hemoglobin level is from about 8 to about 16 g/dl.
2 . The cell culture medium according to claim 1 , wherein the cells present in the blood are disrupted or lysed and the insoluble remnants of the disrupted or lysed cells are removed.
3 . The cell culture medium according to claim 1 , wherein the blood is of mammalian origin.
4 . The cell culture medium according to claim 3 , wherein the blood is of human origin.
5 . The cell culture medium according to claim 1 , wherein the ion content of the medium is restored to match that of the extracellular fraction of total blood starting material.
6 . The cell culture medium according to claim 1 , wherein the low molecular weight (<3000 Dalton) nutrient content and/or composition is essentially the same as that of a medium selected form the group consisting of Roswell Park Memorial Institute (RPMI) medium, Dulbecco's Modified Eagle's Medium (DMEM), and Isocove's Modified Dulbecco's Medium (IMDM).
7 . The cell culture medium according to claim 1 , wherein the reducing capacity of the medium is restored by addition of reduced glutathione.
8 . (canceled)
9 . A method for the preparation of the cell culture medium for culturing human cells of claim 1 , said method comprising
(a) providing anti-coagulated mammalian blood as starting material; (b) mechanically disrupting or lysing the cells present in the blood; (c) removing the insoluble remnants of the disurupted or lysed cells.
10 . The method according to claim 9 , wherein the mechanical disruption of the cells is achieved by freezing the total blood or by ultrasound, electric blade homogenizer or French press.
11 . The method according to claim 9 , wherein removal of the insoluble remnants of the lysated cells is achieved by ultracentrifugation or mechanical filtration.
12 . The method according to claim 9 , wherein the low molecular weight (<3000 Dalton) content and/or composition of the medium is adjusted by dialysis against conventional cell culture medium selected form the group consisting of RPMI, DMEM, and IMDM.
13 . The method according to claim 9 , wherein the reducing capacity of the medium is restored by addition of reduced glutathione.
14 . Cell culture medium for culturing human cells, obtainable by the method according to claim 9 .
15 . (canceled)
16 . The cell culture medium according to claim 1 , wherein said culture medium is prepared by
(a) obtaining mammalian blood having an extracellular fraction, as starting material; (b) adding an anticoagulant to the mammalian blood thereby providing anti-coagulated mammalian blood; (c) mechanically disrupting or lysing the cells present in the anti-coagulated mammalian blood; (d) removing insoluble remnants of the disrupted or lysed cells to produce a particle-free extract; (e) modifying the ion content of the particle-free extract to match the extracellular fraction of the starting material or to be similar to that of a medium selected form the group consisting of Dulbecco's Modified Eagle's Medium (DMEM), Roswell Park Memorial Institute (RPMI) medium and Isocove's Modified Dulbecco's Medium (IMDM).
17 . The cell culture medium according to claim 16 , wherein the growth and survival factor flora of the starting material is preserved in the culture medium.
18 . The cell culture medium according to claim 16 , wherein the anticoagulant is heparin.
19 . The cell culture medium according to claim 16 , wherein the disrupting or lysing of the cells achieves an even disruption of cell membranes of the cells.
20 . The cell culture medium according to claim 16 , wherein the culturing medium contains all macromolecular components of the blood.
21 . The cell culture medium according to claim 16 , wherein the mechanical disruption or lysing of the cells is achieved by freezing the total blood.Join the waitlist — get patent alerts
Track US2018080006A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.